subject: European Markets for Neurological Devices 2010 (15 Countries) (Executive Summary) [print this page] European Markets for Neurological Devices 2010 (15 Countries) (Executive Summary)
In 2009, the European market for neurological devices was valued at almost 500 million. This report covers Austria, Benelux, France, Germany, Italy, Portugal, Scandinavia, Spain, Switzerland and the United Kingdom. Growth in this market is driven by the continued acceptance of endovascular techniques and neuromodulation devices.
This market includes:
Cerebrospinal fluid (CSF) shunts
CSF drainage systems
Detachable coils
Liquid embolics
Neurovascular catheters
Neurovascular guidewires
Neurovascular stents
Spinal cord stimulators
Vagus nerve stimulators
Deep brain stimulators
Sacral nerve stimulators
Gastric electric stimulators
Transcranial magnetic stimulators
Stereotactic systems and
Neurosurgical microscopes
Within the for neurological device market, companies such as Boston Scientific, Carl Zeiss, Codman, Medtronic and St. Jude lead the market, among many others. This report provides a comprehensive and detailed analysis of market revenues by device type, market forecasts through 2016, unit sales, average selling prices, market drivers and limiters and a detailed competitive analysis, including manufacturer market shares and product portfolios.
EXECUTIVE SUMMARY
1.1MARKET OVERVIEW
1.2 CEREBROSPINAL FLUID (CSF) SHUNT MARKET
1.3 CSF EXTERNAL DRAINAGE SYSTEM MARKET
1.4 DETACHABLE COIL MARKET
1.5 LIQUID EMBOLICS
1.6 NEUROVASCULAR CATHETER MARKET
1.7 NEUROVASCULAR STENTS
1.8 NEUROVASCULAR GUIDEWIRE MARKET
1.9 NEUROMODULATION MARKET
1.9.1 Spinal Cord Stimulation Market
1.9.2 Vagus Nerve Stimulation Market
1.9.3 Deep Brain Stimulation Market
1.9.4 Sacral Nerve Stimulation Market
1.9.5 Gastric Electric Stimulation Market
1.10 TRANSCRANIAL MAGNETIC STIMULATION MARKET
1.11 STEREOTACTIC MARKET
1.12 NEUROSURGICAL MICROSCOPE MARKET
1.13 COMPETITIVE ANALYSIS
In 2009, the European market for neurological devices was valued at almost 500 million. This report covers Austria, Benelux, France, Germany, Italy, Portugal, Scandinavia, Spain, Switzerland and the United Kingdom. Growth in this market is driven by the continued acceptance of endovascular techniques and neuromodulation devices.
